在接受化疗的女性患者中失眠和相关因素的患病率
Halil Taskaynatan1, Betul Ersoz1, Ufuk Camanli1
1Department of Medical Oncology, University of Health Sciences, Izmir City Hospital, Izmir, Turkey.
Nature and science of sleep
|October 14, 2025
概括
在接受化疗的女性癌症患者中,失眠是常见的. 年龄较小,疼痛和精神问题如抑郁和焦虑与更高的失眠率有关,影响生活质量.
科学领域:
- 在瘤学瘤学.
- 精神病学是一个精神病学.
- 生活质量研究 研究 生命质量研究
背景情况:
- 失眠严重影响正在接受化疗的女性癌症患者的身体和心理健康.
- 解决失眠问题对于改善这些患者的整体生活质量至关重要.
研究的目的:
- 为了确定在接受化疗的女性癌症患者中失眠的患病率.
- 在这个患者群体中确定与失眠相关的因素.
主要方法:
- 一项涉及206名接受化疗的女性癌症患者的横截面研究.
- 通过关于社会人口统计和临床特征的问卷收集的数据.
- 失眠严重程度指数 (ISI) 用于测量失眠.
主要成果:
- 34.0%的人患有亚临床失眠,17.0%的人患有临床失眠.
- 年龄较小,疼痛的存在和精神伴随性疾病 (抑郁症/焦虑症) 与更高的失眠严重程度有关.
- 与非转移性 (35.0%) 相比,转移性疾病的妇科癌症患者报告了更高的失眠率 (76.2%).
结论:
- 在接受化疗的女性癌症患者中,失眠非常普遍.
- 关键的相关因素包括年龄较小,疼痛,精神病并发症和转移性疾病.
- 查和治疗失眠可以提高整体癌症护理和患者的生活质量.
相关概念视频
Insomnia
406
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
406
Management of Insomnia
536
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
536
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
599
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
599
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
583
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
583
Disorders of the Female Reproductive System
3.8K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
3.8K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
808
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
808

